{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T10:25:13Z","timestamp":1756463113649},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,2,9]],"date-time":"2010-02-09T00:00:00Z","timestamp":1265673600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1007\/s12185-010-0503-2","type":"journal-article","created":{"date-parts":[[2010,2,8]],"date-time":"2010-02-08T02:59:31Z","timestamp":1265597971000},"page":"522-524","source":"Crossref","is-referenced-by-count":10,"title":["Myasthenia gravis developing in a patient with CNS lymphoma"],"prefix":"10.1007","volume":"91","author":[{"given":"Rami","family":"Masroujeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaher K.","family":"Otrock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bassem","family":"Yamout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark N.","family":"Jabbour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Bazarbachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,2,9]]},"reference":[{"key":"503_CR1","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/ncpneuro0395","volume":"3","author":"FH Hochberg","year":"2007","unstructured":"Hochberg FH, Baehring JM, Hochberg EP. Primary CNS lymphoma. Nat Clin Pract Neurol. 2007;3:24\u201335.","journal-title":"Nat Clin Pract Neurol."},{"key":"503_CR2","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/cncr.10851","volume":"95","author":"JE Olson","year":"2000","unstructured":"Olson JE, Janney CA, Rao RD, et al. The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: a surveillance, epidemiology, and end results analysis. Cancer. 2000;95:1504\u201310.","journal-title":"Cancer."},{"key":"503_CR3","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1200\/JCO.2000.18.19.3325","volume":"18","author":"A Cingolani","year":"2000","unstructured":"Cingolani A, Gastaldi R, Fassoneet L, et al. Epstein\u2013Barr virus infection is predictive of CNS involvement in systemic AIDS related non-Hodgkin\u2019s lymphomas. J Clin Oncol. 2000;18:3325\u201330.","journal-title":"J Clin Oncol"},{"key":"503_CR4","first-page":"229","volume":"2","author":"TG Phan","year":"2000","unstructured":"Phan TG, O\u2019Neill BP, Kurtin PJ. Posttransplant primary CNS lymphoma. Neurooncology. 2000;2:229\u201338.","journal-title":"Neurooncology."},{"key":"503_CR5","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/S0140-6736(00)05186-2","volume":"357","author":"A Vincent","year":"2001","unstructured":"Vincent A, Palace J, Hilton-Jones D. Myasthenia gravis. Lancet. 2001;357:2122\u20138.","journal-title":"Lancet"},{"key":"503_CR6","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/j.1468-1331.2008.02242.x","volume":"15","author":"GO Skeie","year":"2008","unstructured":"Skeie GO, Romi F. Paraneoplastic myasthenia gravis: immunological and clinical aspects. Eur J Neurol. 2008;15:1029\u201333.","journal-title":"Eur J Neurol"},{"key":"503_CR7","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1097\/NEN.0b013e31818beaea","volume":"67","author":"BK Kleinschmidt-DeMasters","year":"2008","unstructured":"Kleinschmidt-DeMasters BK, Damek DM, Lillehei KO, Dogan A, Giannini C. Epstein\u2013Barr virus-associated primary CNS lymphomas in elderly patients on immunosuppressive medications. J Neuropathol Exp Neurol. 2008;67:1103\u201311.","journal-title":"J Neuropathol Exp Neurol."},{"key":"503_CR8","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11060-004-5676-1","volume":"74","author":"PF Finelli","year":"2005","unstructured":"Finelli PF. Primary CNS lymphoma in myasthenic on long-term azathioprine. J Neurooncol. 2005;74:91\u20132.","journal-title":"J Neurooncol"},{"key":"503_CR9","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s004010051185","volume":"99","author":"U Herrlinger","year":"2000","unstructured":"Herrlinger U, Klingel K, Meyermann R, et al. Central nervous system Hodgkin\u2019s lymphoma without systemic manifestation: case report and review of the literature. Acta Neuropathol. 2000;99:709\u201314.","journal-title":"Acta Neuropathol"},{"key":"503_CR10","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1212\/01.wnl.0000173031.56429.04","volume":"65","author":"S Vernino","year":"2005","unstructured":"Vernino S, Salomao DR, Habermann TM, O\u2019Neill BP. Primary CNS lymphoma complicating treatment of myasthenia gravis with mycophenolate mofetil. Neurology. 2005;65:639\u201341.","journal-title":"Neurology."},{"key":"503_CR11","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1136\/jnnp.72.2.271","volume":"72","author":"PN Shams","year":"2002","unstructured":"Shams PN, Waldman A, Plant GT. B Cell lymphoma of the brain stem masquerading as myasthenia. J Neurol Neurosurg Psychiatry. 2002;72:271\u20133.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"503_CR12","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1093\/annonc\/mdm010","volume":"18","author":"P Kumar","year":"2007","unstructured":"Kumar P, Jain P, Menon H, Purvish P. Chronic myeloid leukemia presenting as paraneoplastic ocular myasthenia gravis. Ann Oncol. 2007;18:804\u20135.","journal-title":"Ann Oncol"},{"key":"503_CR13","first-page":"55","volume":"25","author":"MA Lastowska","year":"1994","unstructured":"Lastowska MA. Myasthenic syndrome associated with relapse of Hodgkin\u2019s disease. Acta Haematol Pol. 1994;25:55\u20138.","journal-title":"Acta Haematol Pol"},{"key":"503_CR14","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1212\/WNL.45.5.1019","volume":"45","author":"LE Abrey","year":"1995","unstructured":"Abrey LE. Association of myasthenia gravis with extrathymic Hodgkin\u2019s lymphoma: complete resolution of myasthenic symptoms following antineoplastic therapy. Neurology. 1995;45:1019.","journal-title":"Neurology."},{"key":"503_CR15","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/ajh.20169","volume":"77","author":"A Gajra","year":"2004","unstructured":"Gajra A, Vajpayee N, Grethlein SJ. Response of myasthenia gravis to rituximab in a patient with non-Hodgkin lymphoma. Am J Hematol. 2004;77:196\u20137.","journal-title":"Am J Hematol"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-010-0503-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-010-0503-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-010-0503-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T05:01:30Z","timestamp":1559451690000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-010-0503-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,9]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["503"],"URL":"https:\/\/doi.org\/10.1007\/s12185-010-0503-2","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,9]]}}}